Analysis and simulation for a two-sex transmission model of HPV infection in Xinjiang of China
Infectious Disease Modelling · 2026-12 · 11 (4) · 1387-1412
DOI: 10.1016/j.idm.2026.04.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Disease Modelling, 2026-12. Verfasst von He Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830017, PR China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xinjiang Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830017, PR China.
- School of Public Health, Xinjiang Medical University, Urumqi, 830017, PR China.
- Institute of Medical Engineering Interdisciplinary Research, Xinjiang Medical University, Urumqi, 830017, PR China.
Förderung
- Xinjiang Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zhao, H., Abuduwaili, S., Teng, Z., Wang, L., Rifhat, R., & Zhang, Z. (2026). Analysis and simulation for a two-sex transmission model of HPV infection in Xinjiang of China. Infectious Disease Modelling, 11(4), 1387-1412. https://doi.org/10.1016/j.idm.2026.04.009
Vancouver
Zhao H, Abuduwaili S, Teng Z, Wang L, Rifhat R, Zhang Z. Analysis and simulation for a two-sex transmission model of HPV infection in Xinjiang of China. Infectious Disease Modelling. 2026;11(4):1387-1412. doi:10.1016/j.idm.2026.04.009
BibTeX
@article{Zhao2026,
author = {Zhao, He and Abuduwaili, Shayidan and Teng, Zhidong and Wang, Lei and Rifhat, Ramziya and Zhang, Zihan},
title = {Analysis and simulation for a two-sex transmission model of HPV infection in Xinjiang of China},
journal = {Infectious Disease Modelling},
year = {2026},
volume = {11},
number = {4},
pages = {1387--1412},
doi = {10.1016/j.idm.2026.04.009}
}
EUVIMED